Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 126

1.

iTRAQ and multiple reaction monitoring as proteomic tools for biomarker search in cerebrospinal fluid of patients with Parkinson's disease dementia.

Lehnert S, Jesse S, Rist W, Steinacker P, Soininen H, Herukka SK, Tumani H, Lenter M, Oeckl P, Ferger B, Hengerer B, Otto M.

Exp Neurol. 2012 Apr;234(2):499-505. doi: 10.1016/j.expneurol.2012.01.024. Epub 2012 Feb 1.

PMID:
22327139
[PubMed - indexed for MEDLINE]
2.

CSF amyloid-beta-peptides in Alzheimer's disease, dementia with Lewy bodies and Parkinson's disease dementia.

Bibl M, Mollenhauer B, Esselmann H, Lewczuk P, Klafki HW, Sparbier K, Smirnov A, Cepek L, Trenkwalder C, Rüther E, Kornhuber J, Otto M, Wiltfang J.

Brain. 2006 May;129(Pt 5):1177-87. Epub 2006 Apr 6.

PMID:
16600985
[PubMed - indexed for MEDLINE]
Free Article
3.

Differential sialylation of serpin A1 in the early diagnosis of Parkinson's disease dementia.

Jesse S, Lehnert S, Jahn O, Parnetti L, Soininen H, Herukka SK, Steinacker P, Tawfik S, Tumani H, von Arnim CA, Neumann M, Kretzschmar HA, Kulaksiz H, Lenter M, Wiltfang J, Ferger B, Hengerer B, Otto M.

PLoS One. 2012;7(11):e48783. doi: 10.1371/journal.pone.0048783. Epub 2012 Nov 8.

PMID:
23144969
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Cerebrospinal fluid biomarkers in Parkinson's disease with dementia and dementia with Lewy bodies.

Parnetti L, Tiraboschi P, Lanari A, Peducci M, Padiglioni C, D'Amore C, Pierguidi L, Tambasco N, Rossi A, Calabresi P.

Biol Psychiatry. 2008 Nov 15;64(10):850-5. doi: 10.1016/j.biopsych.2008.02.016. Epub 2008 Apr 8.

PMID:
18395699
[PubMed - indexed for MEDLINE]
5.

Beta-amlyoid 1-42 and tau-protein in cerebrospinal fluid of patients with Parkinson's disease dementia.

Mollenhauer B, Trenkwalder C, von Ahsen N, Bibl M, Steinacker P, Brechlin P, Schindehuette J, Poser S, Wiltfang J, Otto M.

Dement Geriatr Cogn Disord. 2006;22(3):200-8. Epub 2006 Aug 7.

PMID:
16899997
[PubMed - indexed for MEDLINE]
6.

Detection of biomarkers with a multiplex quantitative proteomic platform in cerebrospinal fluid of patients with neurodegenerative disorders.

Abdi F, Quinn JF, Jankovic J, McIntosh M, Leverenz JB, Peskind E, Nixon R, Nutt J, Chung K, Zabetian C, Samii A, Lin M, Hattan S, Pan C, Wang Y, Jin J, Zhu D, Li GJ, Liu Y, Waichunas D, Montine TJ, Zhang J.

J Alzheimers Dis. 2006 Aug;9(3):293-348.

PMID:
16914840
[PubMed - indexed for MEDLINE]
7.

Combined dementia-risk biomarkers in Parkinson's disease: a prospective longitudinal study.

Compta Y, Pereira JB, Ríos J, Ibarretxe-Bilbao N, Junqué C, Bargalló N, Cámara A, Buongiorno M, Fernández M, Pont-Sunyer C, Martí MJ.

Parkinsonism Relat Disord. 2013 Aug;19(8):717-24. doi: 10.1016/j.parkreldis.2013.03.009. Epub 2013 May 3. Erratum in: Parkinsonism Relat Disord. 2013 Nov;19(11):1071-2.

PMID:
23643469
[PubMed - indexed for MEDLINE]
8.

Tau protein concentrations in cerebrospinal fluid of non-demented Parkinson's disease patients.

Molina JA, Benito-León J, Jiménez-Jiménez FJ, Ortí-Pareja M, Berbel A, Tallón-Barranco A, de Bustos F, Hernánz A.

Neurosci Lett. 1997 Dec 5;238(3):139-41.

PMID:
9464639
[PubMed - indexed for MEDLINE]
9.

Cerebrospinal hypocretin, daytime sleepiness and sleep architecture in Parkinson's disease dementia.

Compta Y, Santamaria J, Ratti L, Tolosa E, Iranzo A, Muñoz E, Valldeoriola F, Casamitjana R, Ríos J, Marti MJ.

Brain. 2009 Dec;132(Pt 12):3308-17. doi: 10.1093/brain/awp263. Epub .

PMID:
19858078
[PubMed - indexed for MEDLINE]
Free Article
10.

Amyloid-β and τ biomarkers in Parkinson's disease-dementia.

Buongiorno M, Compta Y, Martí MJ.

J Neurol Sci. 2011 Nov 15;310(1-2):25-30. doi: 10.1016/j.jns.2011.06.046. Epub 2011 Jul 20. Review.

PMID:
21764078
[PubMed - indexed for MEDLINE]
11.

Somatostatin-like immunoreactivity in the cerebrospinal fluid of patients with Parkinson's disease and its relation to dementia.

Jolkkonen J, Soininen H, Halonen T, Ylinen A, Laulumaa V, Laakso M, Riekkinen P.

J Neurol Neurosurg Psychiatry. 1986 Dec;49(12):1374-7.

PMID:
2433403
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Diagnostic cerebrospinal fluid biomarkers for Parkinson's disease: a pathogenetically based approach.

van Dijk KD, Teunissen CE, Drukarch B, Jimenez CR, Groenewegen HJ, Berendse HW, van de Berg WD.

Neurobiol Dis. 2010 Sep;39(3):229-41. doi: 10.1016/j.nbd.2010.04.020. Epub 2010 May 6. Review.

PMID:
20451609
[PubMed - indexed for MEDLINE]
13.

Cerebrospinal fluid inflammatory markers in Parkinson's disease--associations with depression, fatigue, and cognitive impairment.

Lindqvist D, Hall S, Surova Y, Nielsen HM, Janelidze S, Brundin L, Hansson O.

Brain Behav Immun. 2013 Oct;33:183-9. doi: 10.1016/j.bbi.2013.07.007. Epub 2013 Jul 31.

PMID:
23911592
[PubMed - indexed for MEDLINE]
Free Article
14.

Neurochemical markers in the cerebrospinal fluid of patients with Alzheimer's disease, Parkinson's disease and amyotrophic lateral sclerosis and normal controls.

Hartikainen P, Reinikainen KJ, Soininen H, Sirviö J, Soikkeli R, Riekkinen PJ.

J Neural Transm Park Dis Dement Sect. 1992;4(1):53-68.

PMID:
1347220
[PubMed - indexed for MEDLINE]
15.

CSF amyloid-beta and tau proteins, and cognitive performance, in early and untreated Parkinson's disease: the Norwegian ParkWest study.

Alves G, Brønnick K, Aarsland D, Blennow K, Zetterberg H, Ballard C, Kurz MW, Andreasson U, Tysnes OB, Larsen JP, Mulugeta E.

J Neurol Neurosurg Psychiatry. 2010 Oct;81(10):1080-6. doi: 10.1136/jnnp.2009.199950. Epub 2010 Jun 14.

PMID:
20547614
[PubMed - indexed for MEDLINE]
16.

Coexisting dementia and depression in Parkinson's disease.

Sano M, Stern Y, Williams J, Coté L, Rosenstein R, Mayeux R.

Arch Neurol. 1989 Dec;46(12):1284-6.

PMID:
2480103
[PubMed - indexed for MEDLINE]
17.

Parkinson's disease and dementia: a longitudinal study (DEMPARK).

Balzer-Geldsetzer M, Costa AS, Kronenbürger M, Schulz JB, Röske S, Spottke A, Wüllner U, Klockgether T, Storch A, Schneider C, Riedel O, Wittchen HU, Seifried C, Hilker R, Schmidt N, Witt K, Deuschl G, Mollenhauer B, Trenkwalder C, Liepelt-Scarfone I, Gräber-Sultan S, Berg D, Gasser T, Kalbe E, Bodden M, Oertel WH, Dodel R.

Neuroepidemiology. 2011;37(3-4):168-76. doi: 10.1159/000331490. Epub 2011 Nov 4.

PMID:
22067139
[PubMed - indexed for MEDLINE]
18.

T1rho (T1ρ) MR imaging in Alzheimer's disease and Parkinson's disease with and without dementia.

Haris M, Singh A, Cai K, Davatzikos C, Trojanowski JQ, Melhem ER, Clark CM, Borthakur A.

J Neurol. 2011 Mar;258(3):380-5. doi: 10.1007/s00415-010-5762-6. Epub 2010 Oct 7.

PMID:
20924593
[PubMed - indexed for MEDLINE]
19.

Proteomic biomarker discovery in cerebrospinal fluid for neurodegenerative diseases.

Zhang J, Goodlett DR, Montine TJ.

J Alzheimers Dis. 2005 Mar;8(4):377-86. Review.

PMID:
16556969
[PubMed - indexed for MEDLINE]
20.

Cerebrospinal fluid proteomic patterns discriminate Parkinson's disease and multiple system atrophy.

Ishigami N, Tokuda T, Ikegawa M, Komori M, Kasai T, Kondo T, Matsuyama Y, Nirasawa T, Thiele H, Tashiro K, Nakagawa M.

Mov Disord. 2012 Jun;27(7):851-7. doi: 10.1002/mds.24994. Epub 2012 Jun 1.

PMID:
22674850
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk